After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CYTK belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Cytokinetics Inc is $7.30B. A total of 2.17 million shares were traded on the day, compared to an average of 2.15M shares.
In the most recent transaction, Malik Fady Ibraham sold 2,000 shares of CYTK for 60.56 per share on Oct 07 ’25. After the transaction, the EVP Research & Development now owns 140,610 company shares. In a previous transaction on Oct 06 ’25, Kaye Edward M. MD sold 6,757 shares at 60.00 per share. CYTK shares that Director owns now total 9,778.
Among the insiders who bought shares, EDWARD KAYE acquired of 6,757 shares on Oct 06 ’25 at a per-share price of $56.97. In another insider transaction, ROBERT BLUM bought 15,000 shares at $54.96 per share on Oct 01 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CYTK has a high of $61.48 and a low of $29.31.
As of this writing, CYTK has an earnings estimate of -$1.57 per share for the current quarter. EPS was calculated based on a consensus of 16.0 estimates, with a high estimate of -$1.29 per share and a lower estimate of -$1.81. The company reported an EPS of -$1.36 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CYTK’s latest balance sheet shows that the firm has $471.64M in Cash & Short Term Investments as of fiscal 2021. There were $269.93M in debt and $71.86M in liabilities at the time. Its Book Value Per Share was -$3.08, while its Total Shareholder’s Equity was $243.86M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.